Differently, when we compared periphery and tissue sites, we observed a heterogeneous phenotype and functionality of CD8+ T cells, also in terms of polyfunctionality and frequency of CD103+CD69+ T-resident as well as CD39+CD127- T-cell subsets, recently described as the major tumor-reactive T cells [5, 6]. The gene discussed is ENTPD1; the disease is neoplasm.